EUVIMEDEUVIMED entdecken
Crossref

Roadmap to genomic inclusivity: collaboration to achieve efficient, affordable, and accessible genetic testing for Southeast Asia

Vincentius Simeon Weo Budhyanto, Stefanie Jürgens, Jonas Korlach, Cindy Oktavi Cicilia, Zuhrah Taufiqa

Journal of Biochemical and Clinical Genetics · 2026

DOI: 10.24911/jbcgenetics.11-3072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Clinical Genetics, 2026. Verfasst von Vincentius Simeon Weo Budhyanto und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Southeast Asia's approximately 700 million people contribute only a small fraction of the data underpinning global genomic reference resources. The clinical consequences are elevated rates of variants of uncertain significance, polygenic risk scores that transfer poorly across ancestries, and screening calibrated to non-representative populations. The equity case is established; the operational case is not.

Methods

We searched PubMed/MEDLINE, ScienceDirect and Google Scholar from 1 January 2010 to 31 March 2026, with a targeted documentation update on 5 August 2026. Sequencing requirements were modeled by applying phased clinical penetration rates to demographic and epidemiological denominators, with instrument counts derived at 70% utilization. Every input and formula is published as a supplementary workbook, and outputs are bounded by sensitivity analysis.

Results

Capacity is profoundly uneven, from more than 50,000 completed genomes in Singapore to none in Timor-Leste. The eleven member states record approximately 10.6 million annual births and 1.15 million incident cancers. At maturity the base case yields approximately 46.0 petabases annually (23.0-56.8 across scenarios), requiring approximately 42 short-read instruments (23 throughput-derived, 7 buffer, 12 mid-throughput) and a mixed long-read fleet of approximately 22. Modeled fifteen-year infrastructure investment is US$733 million (US$644 million to US$1.0 billion), or US$0.07 per capita annually, excluding recurrent testing at US$5.3-12.2 per capita annually.

Conclusion

Long-read sequencing is a required regional capability for structurally complex loci, alongside validated targeted assays. Specialist workforce, not hardware, is the most acute constraint identified where data exist. We propose a federated hub-and-spoke architecture aligned to the proposed ASEAN Genome Consortium.

Zitieren

APA

Budhyanto, V. S. W., Jürgens, S., Korlach, J., Cicilia, C. O., & Taufiqa, Z. (2026). Roadmap to genomic inclusivity: collaboration to achieve efficient, affordable, and accessible genetic testing for Southeast Asia. Journal of Biochemical and Clinical Genetics. https://doi.org/10.24911/jbcgenetics.11-3072

Vancouver

Budhyanto VSW, Jürgens S, Korlach J, Cicilia CO, Taufiqa Z. Roadmap to genomic inclusivity: collaboration to achieve efficient, affordable, and accessible genetic testing for Southeast Asia. Journal of Biochemical and Clinical Genetics. 2026. doi:10.24911/jbcgenetics.11-3072

BibTeX
@article{Budhyanto2026,
  author = {Budhyanto, Vincentius Simeon Weo and Jürgens, Stefanie and Korlach, Jonas and Cicilia, Cindy Oktavi and Taufiqa, Zuhrah},
  title = {Roadmap to genomic inclusivity: collaboration to achieve efficient, affordable, and accessible genetic testing for Southeast Asia},
  journal = {Journal of Biochemical and Clinical Genetics},
  year = {2026},
  doi = {10.24911/jbcgenetics.11-3072}
}
Kostenlos starten →